Get started
Author

Yoshioki Yamasaki

Observed names: Y Yamasaki, Y. Yamasaki, YOSHIOKI YAMASAKI, Yamasaki Y, Yamasaki, Yoshioki
Observed institutions: St. Marianna University School of Medicine, University of Florida Health, Ghent University Hospital, Ghent University, University of Florida, VIB-UGent Center for Inflammation Research, Nippon Medical School
ORCID: 0000-0003-2433-4868
Observed ORCID: 0000-0003-2433-4868
OpenAlex ID: A5066760806
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
2020 · Dinesh Khanna, Celia J F Lin, et al. · The Lancet Respiratory Medicine · 662
PDF
Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis
2006 · Y. Yamasaki, H. Yamada, et al. · Lara D. Veeken · 208
Longterm Survival and Associated Risk Factors in Patients with Adult-onset Idiopathic Inflammatory Myopathies and Amyopathic Dermatomyositis: Experience in a Single Institute in Japan
2011 · YOSHIOKI YAMASAKI, HIDEHIRO YAMADA, et al. · The Journal of Rheumatology · 133
PDF
Unusually high frequency of autoantibodies to PL‐7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis
2006 · Yoshioki Yamasaki, Hidehiro Yamada, et al. · Arthritis & Rheumatism · 114
2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease
2021 · Yasuhiro Kondoh, Shigeki Makino, et al. · Respiratory Investigation · 108
Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis
2010 · Kohei Azuma, Hidehiro Yamada, et al. · Modern Rheumatology · 85
Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis
2011 · Kohei Azuma, Hidehiro Yamada, et al. · Modern Rheumatology · 82
Clinical implication of autoantibodies in patients with systemic rheumatic diseases
2007 · Minoru Satoh, Edward KL Chan, et al. · Expert Review of Clinical Immunology · 76
Citrulline Dependence of Anti-Cyclic Citrullinated Peptide Antibodies in Systemic Lupus Erythematosus as a Marker of Deforming/Erosive Arthritis
2009 · PRASANTHI KAKUMANU, ERIC S. SOBEL, et al. · The Journal of Rheumatology · 71
PDF
Autoantibodies to RNA helicase A: A new serologic marker of early lupus
2007 · Yoshioki Yamasaki, Sonali Narain, et al. · Arthritis & Rheumatism · 52
Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52
2015 · Yoshioki Yamasaki, Minoru Satoh, et al. · Modern Rheumatology · 51
Role of non-protein amino acid l-canavanine in autoimmunity
2005 · Jun Akaogi, Tolga Barker, et al. · Autoimmunity Reviews · 51
Pristane-induced autoimmunity in germ-free mice
2004 · Akiei Mizutani, Victoria M. Shaheen, et al. · Clinical Immunology · 39
Nucleolar staining cannot be used as a screening test for the scleroderma marker anti–RNA polymerase I/III antibodies
2006 · Yoshioki Yamasaki, Minna Honkanen‐Scott, et al. · Arthritis & Rheumatism · 38
Autoantibodies to transcription intermediary factor (TIF)1β associated with dermatomyositis
2012 · Minoru Satoh, Jason YF Chan, et al. · Arthritis Research & Therapy · 27
PDF
Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases
2006 · Yoshioki Yamasaki, Sonali Narain, et al. · Arthritis Research & Therapy · 24
PDF
Lack of partial renal response by 12 weeks after induction therapy predicts poor renal response and systemic damage accrual in lupus nephritis class III or IV
2017 · Hironari Hanaoka, Hidehiro Yamada, et al. · Arthritis Research & Therapy · 23
PDF
Simple exercise echocardiography using a Master's two-step test for early detection of pulmonary arterial hypertension
2013 · Kengo Suzuki, Yoshihiro J. Akashi, et al. · Journal of Cardiology · 22
Low-dose rituximab as induction therapy for ANCA-associated vasculitis
2019 · Yukiko Takakuwa, Hironari Hanaoka, et al. · Clinical Rheumatology · 21
Long‐term survival, causes of death, and prognostic factors for mortality in patients with microscopic polyangiitis and those with anti‐neutrophil cytoplasmic antibody‐positive interstitial lung disease: A single‐center retrospective study
2022 · Yukiko Takakuwa, Yoshioki Yamasaki, et al. · International Journal of Rheumatic Diseases · 17
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
2020 · Khanna, Dinesh, Lin, Celia J.F., et al. · Research at the University of Copenhagen (University of Copenhagen) · 14
Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease
2023 · Yannick Allanore, Dinesh Khanna, et al. · Lara D. Veeken · 12
PDF
Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease
2020 · Yoshioki Yamasaki, Masataka Kuwana · Expert Review of Clinical Immunology · 8
Rhabdomyolysis in a Patient with Polyarteritis Nodosa
2017 · Harunobu Iida, Hironari Hanaoka, et al. · Internal Medicine · 8
PDF
Combined disease with pulmonary arterial hypertension and pulmonary venous hypertension revealed after treatment of heart failure with preserved ejection fraction in a case with primary Sjögren syndrome
2015 · Yoshioki Yamasaki, Kengo Suzuki, et al. · Modern Rheumatology · 6
Works count: 58
Citation count: 1,988
H-index: 19
I10-index: 22
Year
Topic
Type